Brind.

10X Genomics filed its required 13F reports with the Securities and Exchange Commission and its stock continues to trade on the Nasdaq exchange.

6 reports, 3 independent Updated Aug 10
Gone quiet
Reports
6
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

10X Genomics filed its required 13F reports with the Securities and Exchange Commission and its stock continues to trade on the Nasdaq exchange.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. 10X Genomics reported a 27.0% stake reduction in Q1 via SEC filing.1 source
  2. 10X Genomics filed 13F reports with the SEC and its stock trades on the Nasdaq.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story